| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/10/2003 | WO2003028713A2 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 04/10/2003 | WO2003028712A2 Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases |
| 04/10/2003 | WO2003028705A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/10/2003 | WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | WO2003028545A2 Method, instruments, and kit for autologous transplantation |
| 04/10/2003 | WO2003028476A1 Novel enzyme compositions for poultry |
| 04/10/2003 | WO2003017935A9 Human antibodies specific for interleukin 15 (il-15) |
| 04/10/2003 | WO2003004527A3 Novel neurotrophic factors |
| 04/10/2003 | WO2003002598A3 Peptides for use as translocation factors |
| 04/10/2003 | WO2002102394A3 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 04/10/2003 | WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2003 | WO2002092064A3 Therapeutic method for inducing tolerance |
| 04/10/2003 | WO2002081668A8 Desaturase genes and uses thereof |
| 04/10/2003 | WO2002059083A3 Novel compounds |
| 04/10/2003 | WO2002044203A3 Production of recombinant bmp-2 |
| 04/10/2003 | WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same |
| 04/10/2003 | WO2002036175A3 Sustained release device for treating conditions of the joint |
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | US20030069435 Prevention of neutrophil recruitment |
| 04/10/2003 | US20030069428 Pharmaceutically active isoindoline derivatives |
| 04/10/2003 | US20030069425 Substituted pyrimidine compounds and methods of use |
| 04/10/2003 | US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders |
| 04/10/2003 | US20030069303 Osteoporosis, postmenopause |
| 04/10/2003 | US20030069297 4-aryl substituted indolinones |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid |
| 04/10/2003 | US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 04/10/2003 | US20030069255 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| 04/10/2003 | US20030069248 Antiinflammatory agents; controlling cell cycle |
| 04/10/2003 | US20030069244 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 04/10/2003 | US20030069243 Novel substituted imidazole compounds |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/10/2003 | US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents |
| 04/10/2003 | US20030069228 Capase inhibitors; antiinflammatory agents |
| 04/10/2003 | US20030069217 Methods of prevention and treatment of ischemic damage |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 04/10/2003 | US20030069202 Compositions, kits, and methods for promoting defined health benefits |
| 04/10/2003 | US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 04/10/2003 | US20030069175 A cyclic peptide, e.g., cyclic (Tyr-Gly-Phe-Gly-Gly) useful for stimulating the formation of osteoblastic or fibroblastic cells, enhancing bone formation, repairing fractures, healing wounds, grafting intraosseous implants, etc. |
| 04/10/2003 | US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
| 04/10/2003 | US20030068664 Monitoring effectiveness of preferential cancer immunotherapy; obtain mammal, administer immunotherapy, evaluate effectiveness of treatment |
| 04/10/2003 | US20030068429 Inulin products with improved nutritional properties |
| 04/10/2003 | US20030068387 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 04/10/2003 | US20030068315 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 04/10/2003 | US20030068283 Composition |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2462425A1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 04/10/2003 | CA2462424A1 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | CA2462306A1 Method, instruments, and kit for autologous transplantation |
| 04/10/2003 | CA2462143A1 Genetic sequence related to bone diseases |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | CA2461670A1 Indole derivatives as cox ii inhibitors |
| 04/10/2003 | CA2461292A1 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300399A1 Phenylpyridazine derivatives and drugs containing the same |
| 04/09/2003 | EP1300153A1 Use of n-desulfated heparin for treating or preventing inflammations |
| 04/09/2003 | EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 04/09/2003 | EP1299548A1 Novel therapeutic molecular variants and uses thereof |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299357A1 Novel compounds |
| 04/09/2003 | EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/09/2003 | EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives |
| 04/09/2003 | EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 04/09/2003 | EP1299157A1 Composition and applicator for topical substance delivery |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299093A2 Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
| 04/09/2003 | EP1299088A1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient |
| 04/09/2003 | EP1299010A1 Vitamin k and essential fatty acids |
| 04/09/2003 | EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1017681B1 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 04/09/2003 | EP0946165B1 Integrin antagonists |
| 04/09/2003 | EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists |
| 04/09/2003 | EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels |
| 04/09/2003 | EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 04/09/2003 | EP0904272B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 04/09/2003 | EP0874808B1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 04/09/2003 | EP0756483B1 Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis |
| 04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 04/09/2003 | CN1409703A 4-aminopiperidine derivatives and their use as medicine |
| 04/09/2003 | CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder |
| 04/09/2003 | CN1409605A Method for increasing pet activity |
| 04/09/2003 | CN1408410A External use plaster for curing cervical spondylopathy |